Canopy Growth (WEED.TO) Stock Price

Canopy Growth Price

TSX·CLOSED
1.00
​
Market closed

Over the last 16 years Canopy Growth grew revenue by 127.6% annually, reaching 284.60 M CAD. For Canopy Growth, the net margin of -92.4% is down versus -65.2% a few years ago. The consensus 12-month price target for Canopy Growth is 2.09 CAD, about 109.1% above where the stock trades today. Of 13 analysts, 1 rate the stock a buy — an overall Sell consensus.

Canopy Growth stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Canopy Growth business model & stock analysis

Canopy Growth Corp. generates revenue through the production and sale of medical cannabis products under various brands in Canada, with the Canada cannabis segment handling domestic operations. The Rest-of-world cannabis segment sells cannabis products internationally where permitted, while the Storz & Bickel segment focuses on vaporizer sales. BioSteel contributes through consumer packaged goods like sports nutrition products. The company's primary buyers are consumers purchasing recreational and medical cannabis products in Canada, international customers in regions with legal cannabis frameworks, and retail partners for vaporizers and BioSteel products. Segments like Canada cannabis and Rest-of-world cannabis target adult recreational and medical markets, while Storz & Bickel serves users of vaporization devices and BioSteel targets health-conscious consumers. Canopy Growth's brands operate under distinct product lines: Canada cannabis offers a diverse range of cannabis, hemp, and cannabinoid-based products, Rest-of-world cannabis distributes similar products globally within legal boundaries, Storz & Bickel sells vaporizers, and BioSteel provides CPG items including sports nutrition, all contributing to the company's revenue streams.

Frequently asked questions about Canopy Growth

Analysts currently set an average price target of 3.44 CAD for the Canopy Growth stock (median: 2.09 CAD), implying +244.3 % versus the latest price. The consensus is based on 13 analyst ratings.

13 analysts currently rate the Canopy Growth stock: 1 recommend buying, 5 holding and 7 selling.

Converted at the current exchange rate, the Canopy Growth share trades at 0.64 EUR (1.00 CAD).

The Canopy Growth share (WEED.TO) is listed on 8 stock exchanges, including: NYSE (CGC), London (0UO9.L), Toronto (WEED.TO), Frankfurt (11L1.F), München (11L1.MU), Düsseldorf (11L1.DU), Hamburg (11L1.HM).

The revenue of Canopy Growth is 284.60 M CAD. This figure is based on current financial data and reflects the company's business performance.

The profit of Canopy Growth is -262.91 M CAD. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Canopy Growth is currently -1.61. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Canopy Growth stock.

The price-to-sales ratio (P/S) of Canopy Growth is currently 1.48. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Canopy Growth stock.

The Eulerpool Quality Score for Canopy Growth is 4/10.

The ISIN of Canopy Growth is CA1380357048. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of Canopy Growth is A140QA. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of Canopy Growth is WEED.TO. The ticker symbol is used to trade Canopy Growth shares on the stock exchange.

Fair ValueTerminal
0.85 CAD
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Pharmaceuticals
Number of shares
Employees
Revenue per Employee
90,321.49 CAD
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Country
Currency
CAD
Initial public offering
Jun 4, 2010
ISIN
CA1380357048
Cusip
138035100
Sedol
BYTN3W0
Market capitalization
107.55 M CADMicro Cap
52-Week Range
PEG
0.16
P/E ratio
P/Ee 2027
-38.69
P/Ee 2028
-47.41
P/Ee 2029
-60.11
P/Ee 2030
-62.33
P/Ee 2031
-66.00
P/S
P/Se
1.78
EV/EBIT
0.13
P/B Ratio
0.15
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-27.81 %
Last updated Nov 5, 2026, 3:34 AM

Canopy Growth Peer Group

Canopy Growth Ticker

DÜSSELDORF · 11L1.DUFRANKFURT · 11L1.FHAMBURG · 11L1.HMLONDON · 0UO9.LMUNICH · 11L1.MUNASDAQ · CGCNEW YORK · CGCTSX · WEED.TO

All fundamentals and in-depth analysis of Canopy Growth

Our stock analysis for Canopy Growth stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Canopy Growth. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.